Management of obesity-related metabolic comorbidities in adults:a consensus statement and endocrinologist expert recommendations
Endocrinology and Metabolism Professional Committee,National Association of Health Industry and Enterprise Management
MU Yi-ming
YU Xue-feng
ZHU Da-long
Abstract：Obesity-related metabolic comorbidities,such as prediabetes,type 2 diabetes,dyslipidemia,hypertension,hyperuricemia,metabolic dysfuction-associated steatotic liver disease,cardiovascular diseases,obesity-related glomerulopathy,and polycystic ovary syndrome,are the most common challenges for endocrinologist.The core features involve metabolic disorders triggered by insulin resistance and a chronic low-grade inflammatory state.These conditions collectively elevate the risk of multisystem health complications and cardiovascular mortality.Proactive prevention and treatment of obesity and its metabolic comorbidities are crucial for reducing healthcare expenditures and improving patients'quality of life.
Keywords：obesitymetabolic comorbiditiesconsensusexpert recommendation
Publication Date：2025-08-01
Online Publishing Date：2025-10-09(First online date of this platform, not the publication date of the document)
Pages：15( 656-670 )